Induced pluripotent stem cells: past, present, and future.
By S. Yamanaka. Cell Stem Cell, 2012
838 citations recorded by the source corpus.
Subfields: Cognitive Neuroscience, Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/7c98b67a36cc5f6c4f8b9e0527c621265f70bab1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cognitive Neuroscience
In Molecular Biology
In Physiology
Citations in the corpus
- Transcriptional Addiction in Cancer (2017, neutral): “, 2009), a small number of master TFs, sometimes called lineage regulators, are sufficient to establish control of the gene expression programs that define cell identity (Buganim et al., 2013; Graf and Enver, 2009; Lee and Young, 2013; Morris and Daley, 2013; Sancho-Martinez et al., 2012; Vierbuchen”
- Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3 (2016, neutral): “Advances in embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) technology have opened up new avenues of disease modeling in vitro (Yamanaka, 2012).”
- Transcriptional Regulation and its Misregulation in Disease (2013, neutral): “…in ESCs, only a few of these transcription factors are needed to reprogram a broad range of cell types into induced pluripotent stem cells (iPSCs) with features essentially indistinguishable from ESCs (Graf, 2011; Ng and Surani, 2011; Orkin and Hochedlinger, 2011; Yamanaka, 2012; Yeo Cell.”
- Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip (2016, neutral): “In this framework, induced pluripotent stem cells (iPSCs) hold great promise, due to their wide availability and the possibility to differentiate into multiple cell lineages including cardiomyocytes [3,11,15,16].”
- Progress in corneal wound healing (2015, background): “The success of making lineage-specific differentiated cells from embryonic stem cells (ESC) or induced pluripotent stem cells (iPSC) (Aberdam et al., 2008; Noisa et al., 2012; Yamanaka, 2012) may lead to creation of other bankable and renewable sources of LESC for future transplantation needs.”